Ellagic acid, a new antiglycating agent: its inhibition of Nϵ-(carboxymethyl)lysine. (Q34068791)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22060242%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Ellagic acid, a new antiglycating agent: its inhibition of Nϵ-(carboxymethyl)lysine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22060242%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22060242%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Puppala Muthenna

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22060242%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Chandrasekhar Akileshwari

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22060242%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

language of work or name

English

0 references

publication date

1 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22060242%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

Biochemical Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22060242%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

442

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22060242%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22060242%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

221-230

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22060242%20AND%20SRC:MED&resulttype=core&format=json

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Advanced glycation end-products: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Advanced glycation endproducts--role in pathology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Advanced protein glycosylation in diabetes and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Advanced glycation end-products and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Lipid glycation and protein glycation in diabetes and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Effect of dicarbonyl-induced browning on alpha-crystallin chaperone-like activity: physiological significance and caveats of in vitro aggregation assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Effect of glycation on alpha-crystallin structure and chaperone-like function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Increased protein glycation in cerebrospinal fluid of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Accumulation of Maillard reaction products in skin collagen in diabetes and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

An agent cleaving glucose-derived protein crosslinks in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Novel inhibitors of advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Evaluation of the anti-inflammatory effects of ellagic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Multitargeted therapy of cancer by ellagitannins

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Prevention of non-enzymic glycation of proteins by dietary agents: prospects for alleviating diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Delay of diabetic cataract in rats by the antiglycating potential of cumin through modulation of alpha-crystallin chaperone activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Effect of nonenzymatic glycation on functional and structural properties of hemoglobin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Tomato paste fraction inhibiting the formation of advanced glycation end-products

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Chelating activity of advanced glycation end-product inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

A new rapid method to detect inhibition of Amadori product generated by delta-gluconolactone

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Effects of OPB-9195, anti-glycation agent, on experimental diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Antioxidative activity, polyphenolic content and anti-glycation effect of some Thai medicinal plants traditionally used in diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Protective activity of green tea against free radical- and glucose-mediated protein damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Safety assessment of ellagic acid, a food additive, in a subchronic toxicity study using F344 rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Hypothesis: the 'metabolic memory', the new challenge of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110846

21 January 2018

Identifiers

DOI

10.1042/BJ20110846

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22060242%20AND%20SRC:MED&resulttype=core&format=json

release_6tv7pdffwbahvmatjsqqdowkc4

16 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6tv7pdffwbahvmatjsqqdowkc4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference